Cannabidiol

25 trials 7 recruiting NNeurology/Psychiatry Orphan designation

Filter these 25 trials by condition, phase, country and more.

Open in Search →

25 Registered trials

7 Recruiting

10 Completed trials

20 Sponsors

10 Countries

Phase III

Phase II

Phase III: 7 Phase II/III: 1 Phase II: 16 Phase III/IV: 1

Oversight events:

1 temporary halt 1 unexpected event across 2 trials

View oversight register →

Indications tested

Tuberous sclerosis complex 2 Alcohol use disorder 1 Lennox-Gastaut syndrome 1 Irritable bowel syndrome 1 Fragile X syndrome 1 Epilepsy 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 2 Cardiol Therapeutics Inc. 2 Harmony Biosciences Management Inc. 2 Institut Gustave Roussy 2 Jazz Pharmaceuticals Research UK Limited 2 Zentralinstitut Fuer Seelische Gesundheit 2 Amsterdam UMC Stichting 1 Azienda Ospedaliera Universitaria Meyer IRCCS 1 Cannabibs Sp. z o.o. 1 Centre for Human Drug Research 1 Centre Hospitalier Le Mans 1 Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico 1

All trials — page 2

25 total

Cannabidiol as an Add-on Treatment to substance abuse in juvenile patients with PSYchosis: a double-blind randomized placebo-controlled stud… Ended

2024-514393-44-00 Phase II 1 country Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

Showing 25–25 of 25 trials

← All drugs A–Z